Enzolytics, Inc. (ENZC)
OTCMKTS · Delayed Price · Currency is USD
0.0007
-0.0002 (-22.22%)
Jul 6, 2026, 1:24 PM EST
Enzolytics Market Cap
Enzolytics has a market cap or net worth of $4.35 million as of July 6, 2026. Its market cap has increased by 28.57% in one year.
Market Cap
4.35M
Enterprise Value
n/a
Revenue
46.59K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 29, 2008, Enzolytics's market cap has decreased from 106.80M to 4.35M, a decrease of -95.93%. That is a compound annual growth rate of -16.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 4.35M | 200.00% |
| Dec 31, 2025 | 1.45M | -68.42% |
| Dec 31, 2024 | 4.59M | -91.73% |
| Dec 29, 2023 | 55.53M | -46.84% |
| Dec 30, 2022 | 104.44M | -45.90% |
| Dec 31, 2021 | 193.06M | -12.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curative Biotechnology | 6.44M |
| TRON Group | 6.44M |
| Mosaic ImmunoEngineering | 4.88M |
| GPL Holdings | 4.20M |
| Orgenesis | 3.92M |
| Pacific Software | 3.44M |
| Eastgate Biotech | 3.17M |
| CASI Pharmaceuticals | 3.02M |